Trial Profile
Effect of combination of bendamustine and rituximab in patients with Waldenstrom's Macroglobulinemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Rituximab (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 13 May 2015 New trial record